Cargando…
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco‐induced lung cancer
Single nucleotide polymorphisms (SNPs) may modulate individual susceptibility to carcinogens. We designed a genome‐wide association study to characterize individuals presenting extreme phenotypes of high and low risk to develop tobacco‐induced non‐small cell lung cancer (NSCLC), and we validated our...
Autores principales: | Fusco, Juan Pablo, Pita, Guillermo, Pajares, María José, Andueza, Maria Pilar, Patiño‐García, Ana, de‐Torres, Juan P., Gurpide, Alfonso, Zulueta, Javier, Alonso, Rosario, Alvarez, Nuria, Pio, Ruben, Melero, Ignacio, Sanmamed, Miguel F., Rodriguez Ruiz, Maria, Gil‐Bazo, Ignacio, Lopez‐Picazo, Jose María, Casanova, Ciro, Baz Davila, Rebeca, Agudo, Antonio, Lozano, Maria Dolores, Gonzalez, Alvaro, Sala, Nuria, Ardanaz, Eva, Benitez, Javier, Montuenga, Luis, Gonzalez‐Neira, Anna, Perez‐Gracia, Jose Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051154/ https://www.ncbi.nlm.nih.gov/pubmed/29766673 http://dx.doi.org/10.1002/cam4.1500 |
Ejemplares similares
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
por: Patiño-García, Ana, et al.
Publicado: (2021) -
The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients
por: Macías, Mónica, et al.
Publicado: (2019) -
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
por: Hsu, Yi-Fan, et al.
Publicado: (2010) -
Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer
por: Ajona, Daniel, et al.
Publicado: (2015) -
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations
por: Aramburu, Ander, et al.
Publicado: (2015)